Literature DB >> 18831878

Chronic fatigue syndrome and the central nervous system.

R Chen1, F X Liang, J Moriya, J Yamakawa, H Sumino, T Kanda, T Takahashi.   

Abstract

An increasing amount of neuroimaging evidence supports the hypothesis that chronic fatigue syndrome patients have structural or functional abnormalities within the brain. Moreover, some neurotrophic factors, neurotransmitters and cytokines have also been evaluated in order to elucidate the mechanism of abnormal neuropsychic findings in chronic fatigue syndrome. In this review, we suggest that the focal point of chronic fatigue syndrome research should be transferred to the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18831878     DOI: 10.1177/147323000803600501

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  17 in total

1.  Structural brain changes versus self-report: machine-learning classification of chronic fatigue syndrome patients.

Authors:  Landrew S Sevel; Jeff Boissoneault; Janelle E Letzen; Michael E Robinson; Roland Staud
Journal:  Exp Brain Res       Date:  2018-05-30       Impact factor: 1.972

Review 2.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

3.  Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study.

Authors:  B K Puri; P M Jakeman; M Agour; K D R Gunatilake; K A C Fernando; A I Gurusinghe; I H Treasaden; A D Waldman; P Gishen
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

4.  Variations in COMT and NTRK2 Influence Symptom Burden in Women Undergoing Breast Cancer Treatment.

Authors:  Erin E Young; Debra Lynch Kelly; Insop Shim; Kyle M Baumbauer; Angela Starkweather; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2017-02-16       Impact factor: 2.522

5.  Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.

Authors:  Jasmine Eshragh; Anand Dhruva; Steven M Paul; Bruce A Cooper; Judy Mastick; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Kord M Kober
Journal:  J Pain Symptom Manage       Date:  2016-10-05       Impact factor: 3.612

6.  Altered Effective Connectivity of Resting-State Networks by Tai Chi Chuan in Chronic Fatigue Syndrome Patients: A Multivariate Granger Causality Study.

Authors:  Yuanyuan Li; Kang Wu; Xiaojie Hu; Tianjiao Xu; Zongheng Li; Yong Zhang; Kuangshi Li
Journal:  Front Neurol       Date:  2022-06-03       Impact factor: 4.086

7.  Characterising eye movement dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Stephen P Badham; Claire V Hutchinson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-06       Impact factor: 3.117

Review 8.  Myalgic encephalomyelitis: International Consensus Criteria.

Authors:  B M Carruthers; M I van de Sande; K L De Meirleir; N G Klimas; G Broderick; T Mitchell; D Staines; A C P Powles; N Speight; R Vallings; L Bateman; B Baumgarten-Austrheim; D S Bell; N Carlo-Stella; J Chia; A Darragh; D Jo; D Lewis; A R Light; S Marshall-Gradisnik; I Mena; J A Mikovits; K Miwa; M Murovska; M L Pall; S Stevens
Journal:  J Intern Med       Date:  2011-08-22       Impact factor: 8.989

9.  Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker.

Authors:  Andrea Byrnes; Andreas Jacks; Karin Dahlman-Wright; Birgitta Evengard; Fred A Wright; Nancy L Pedersen; Patrick F Sullivan
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

10.  Impact of Hepatitis C Virus Infection on Cognitive Function in Patients With Covert Hepatic Encephalopathy.

Authors:  Farnaz Hashemi; Ali Fathi Ashtiani; Babak Mirminachi; Maryam Sharafkhah; Golnaz Ekhlasi; Elham Jafari; Hossein Poustchi
Journal:  Hepat Mon       Date:  2015-07-22       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.